FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34555311000001106: Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Jun 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
104549701000001116 Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
111384101000001116 Mysimba 8mg/90mg modified-release tablets (Orexigen Therapeutics Ireland Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) Is a Naltrexone 8mg / Bupropion 90mg modified-release tablets true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) Has specific active ingredient Naltrexone hydrochloride true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) Has specific active ingredient Bupropion hydrochloride true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Bupropion true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Naltrexone true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) Has excipient Edetate disodium false Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) Is a Mysimba true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) Has active ingredient Naltrexone true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) Has active ingredient Bupropion true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) Has basis of strength substance Bupropion true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) Has basis of strength substance Naltrexone true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) 112 tablet 4 x 28 tablets Has AMP True Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start